News

The latest from Velocity Clinical Research

Velocity Nominated for Two 2025 Vaccine Industry Excellence (ViE) Awards

February 11, 2025

Velocity is a nominee for two 2025 Vaccine Industry Excellence (ViE) Awards! After winning the Best Clinical Trial Company ViE Award in 2024, we would be honored to receive your vote and once again share this recognition with you as we work to improve … Read more

Velocity’s Staszow, Poland, Site Recognized as Leading Global Enroller for Phase 3 Trial

February 7, 2025

Congratulations to our team in Staszów, Poland, and Katarzyna Wawrzyniec-Lis, MD, for being the top global enroller for Boehringer Ingelheim’s Phase 3 cardiovascular safety study for patients with obesity! Velocity is supporting this study at more than 20 sites across the U.S., Poland, and … Read more

Velocity’s VISION Recognized at 2025 SCOPE Site Innovation Awards

February 5, 2025

Thank you to SCOPE Summit for recognizing Velocity at the 2025 Site Innovation Award presentation! Our presentation focused on the way VISION is enhancing trial accessibility for participants worldwide. Now available in four countries and four languages, the VISION Engage mobile app has been … Read more

Velocity Partners with Verified Clinical Trials to Combat Double Enrollment Problem in Clinical Trials

January 30, 2025

Velocity Clinical Research, the leading multi-specialty clinical research organization, has partnered with Verified Clinical Trials (VCT) to set a new benchmark for patient safety and data quality in clinical trials through a new technological implementation at Velocity’s 80+ global sites.  The collaboration addresses a … Read more

Velocity at Scale Enrolls a Greater Number of Participants, Faster

January 27, 2025

In a recent global trial, Velocity sites enrolled participants 50% faster than the average trial site. Additionally, Velocity supported the trial with over 30 research sites across several countries. In another recent trial, Velocity’s 20 sites outpaced average trial site enrollment rate by nearly … Read more

Velocity is a Founding Member of the Association of MultiSite Research Corporations

January 23, 2025

We’re proud to announce that Velocity is a founding member of the newly launched Association of MultiSite Research Corporations (AMRC)! This innovative trade association unites 14 leading organizations to address the systemic challenges in clinical trials and drive meaningful change across the industry. With … Read more

Paul Evans Named Among the Top 50 Healthcare Technology CEOs of 2024

January 8, 2025

Congratulations to Paul Evans for being named one of the Top 50 Healthcare Technology CEOs of 2024! With Paul’s leadership, Velocity continues to redefine how clinical trials are conducted — leveraging VISION technology, centralization, and global site integration to accelerate drug development. His recognition … Read more

Velocity Contributes to ACRP Whitepaper on Responsible AI Oversight

January 7, 2025

Velocity’s team contributed to the new Association of Clinical Research Professionals (ACRP) comprehensive whitepaper, titled ‘Responsible Oversight of Artificial Intelligence for Clinical Research Professionals.’ The development of our VISION technology has coincided with the proliferation of AI and large language models (LLMs). For recruitment … Read more

BioSpace Opinion: The Cocktail Recipe That Will Cure Alzheimer’s

January 6, 2025

Robert Cupelo, MD, Principal Investigator in Syracuse, NY, shares his firsthand insights into the evolving landscape of Alzheimer’s treatment. Nearly two years after the FDA’s approval of lecanemab (Leqembi), and with the subsequent approval of donanemab (Kisunla), researchers are making crucial steps forward in … Read more

Fierce Biotech Article: Paul Evans on Clinical Trials in 2025

December 30, 2024

A new Fierce Biotech article features insights from Paul Evans on what to expect for clinical research in 2025. Topics include rising costs and uncertain regulations, as well as the continued emergence of site networks, AI-driven efficiency (with technology built “by trial sites, for … Read more

2025 Clinical Trials Outlook: Six Industry Trends to Expect

December 23, 2024

Rising costs, evolving regulations, and the unstoppable growth of AI are set to shape clinical trials in 2025. How will sites, new tech, promising obesity drugs, and shifting policies affect our industry? Read this article from Paul Evans featured on PharmiWeb: https://www.pharmiweb.com/article/2025-clinical-trials-outlook-six-industry-trends-to-expect

Henrik Watz Featured in Free Educational Presentation Available for HCPs on COPD with Type 2 Inflammation

December 4, 2024

Congratulations to Henrik Watz, MD, on his exceptional presentation at the 2024 European Respiratory Society (ERS) ADVENT COPD Symposia! Dr. Watz, Medical Director and Principal Investigator at Velocity Clinical Research in Ahrensburg, Germany, joined Drs. Mona Bafadhel and Alberto Papi for a dynamic discussion, … Read more

Learn more about Velocity's capabilities

Whether you’re ready to conduct a single-site study or a complex, high-volume trial, Velocity will ensure you have the right investigators, clinical staff, and patients for your research program.

Join a remarkable team doing remarkable work

Velocity careers offer competitive pay and benefits, and reward high performance with excellent opportunities.

Whether you're an industry veteran or are looking to take your first step into clinical research, we invite you to apply at Velocity.

Quality. Continuity. Velocity.